Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance.
Bellucci E, Chiereghin F, Pacifici F, Donadel G, De Stefano A, Malatesta G, Valente MG, Guadagni F, Infante M, Rovella V, Noce A, Tesauro M, Di Daniele N, Della Morte D, Pastore D.
Bellucci E, et al. Among authors: infante m.
Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):1921-1944. doi: 10.26355/eurrev_202303_31558.
Eur Rev Med Pharmacol Sci. 2023.
PMID: 36930488
Free article.
Review.